Development code · Small Molecule
BNC375
BNC375 is a development code for MK-1167, developed by Merck & Co., Inc..
- Status
- Phase 2 for Alzheimer's disease
- Mechanism
- alpha7 nAChR PAM
- Developer
- Merck & Co., Inc.
Programs
- MK-1167 for Alzheimer's diseasePhase 2Active
Also known as
- MK-1167
- 1557240-80-8